{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:19Z","timestamp":1787067859126,"version":"build-2736575974"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40261-026-01579-3","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:22:20Z","timestamp":1783012940000},"page":"1009-1029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms"],"prefix":"10.1007","volume":"46","author":[{"given":"Elahe","family":"Orak Sarkani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvenaz","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Darash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Monzavi Chaleshtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida","family":"Yahyazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-872X","authenticated-orcid":false,"given":"Omid","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"11","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","volume":"21","author":"JS Brown","year":"2023","unstructured":"Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the definition of cancer. Mol Cancer Res. 2023;21(11):1142\u20137.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"1579_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1579_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1948-5956.100000e2","volume":"1","author":"A Sudhakar","year":"2009","unstructured":"Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009;1(2):1\u20134.","journal-title":"J Cancer Sci Ther."},{"issue":"1","key":"1579_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1570163812666150602144310","volume":"12","author":"TA Baudino","year":"2015","unstructured":"Baudino TA. Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol. 2015;12(1):3\u201320.","journal-title":"Curr Drug Discov Technol"},{"issue":"1","key":"1579_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","volume":"26","author":"T Deli","year":"2020","unstructured":"Deli T, Orosz M, Jakab A. Hormone replacement therapy in cancer survivors - review of the literature. Pathol Oncol Res. 2020;26(1):63\u201378.","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"1579_CR6","first-page":"437","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin. 2021;71(5):437\u201354.","journal-title":"CA Cancer J Clin"},{"key":"1579_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"1579_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321.","journal-title":"Cell Mol Immunol"},{"key":"1579_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137459","author":"A Hassan","year":"2024","unstructured":"Hassan A, Zhao Y, Chen X, He C. Blockage of autophagy for cancer therapy: a comprehensive review. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25137459.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1579_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"1579_CR11","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110031","volume":"41","author":"RC Russell","year":"2022","unstructured":"Russell RC, Guan KL. The multifaceted role of autophagy in cancer. EMBO J. 2022;41(13):e110031.","journal-title":"EMBO J"},{"issue":"7","key":"1579_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","volume":"56","author":"DR Miller","year":"2021","unstructured":"Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Dev Cell. 2021;56(7):906\u201318.","journal-title":"Dev Cell"},{"key":"1579_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121785","author":"N Vlachos","year":"2021","unstructured":"Vlachos N, Lampros M, Voulgaris S, Alexiou GA. Repurposing antipsychotics for cancer treatment. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9121785.","journal-title":"Biomedicines"},{"key":"1579_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101360","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N. Antipsychotic drug fluphenazine against human cancer cells. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101360.","journal-title":"Biomolecules"},{"issue":"1","key":"1579_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jat.4046","volume":"41","author":"M Otreba","year":"2021","unstructured":"Otreba M, Kosmider L. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review J Appl Toxicol. 2021;41(1):82\u201394.","journal-title":"A review. J Appl Toxicol."},{"key":"1579_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020263","author":"M Persico","year":"2022","unstructured":"Persico M, Abbruzzese C, Matteoni S, Matarrese P, Campana AM, Villani V, et al. Tackling the behavior of cancer cells: molecular bases for repurposing antipsychotic drugs in the treatment of glioblastoma. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11020263.","journal-title":"Cells"},{"key":"1579_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","volume":"68","author":"V Shaw","year":"2021","unstructured":"Shaw V, Srivastava S, Srivastava SK. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy. Semin Cancer Biol. 2021;68:75\u201383.","journal-title":"Semin Cancer Biol"},{"key":"1579_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116075","volume":"222","author":"RM Lopes","year":"2024","unstructured":"Lopes RM, Souza ACS, Otreba M, Rzepecka-Stojko A, Tersariol ILS, Rodrigues T. Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy. Biochem Pharmacol. 2024;222:116075.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1579_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00280-021-04386-z","volume":"89","author":"F Xu","year":"2022","unstructured":"Xu F, Xi H, Liao M, Zhang Y, Ma H, Wu M, et al. Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2\/M cell cycle arrest, apoptosis, and autophagy. Cancer Chemother Pharmacol. 2022;89(3):331\u201346.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1579_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24203659","author":"NM Tuan","year":"2019","unstructured":"Tuan NM, Lee CH. Penfluridol as a candidate of drug repurposing for anticancer agent. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24203659.","journal-title":"Molecules"},{"issue":"11","key":"1579_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.15698\/cst2018.11.161","volume":"2","author":"L Vucicevic","year":"2018","unstructured":"Vucicevic L, Misirkic-Marjanovic M, Harhaji-Trajkovic L, Maric N, Trajkovic V. Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs. Cell Stress. 2018;2(11):282\u201391.","journal-title":"Cell Stress"},{"key":"1579_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123675","author":"O Camuzard","year":"2020","unstructured":"Camuzard O, Trojani MC, Santucci-Darmanin S, Pagnotta S, Breuil V, Carle GF, et al. Autophagy in osteosarcoma cancer stem cells is critical process which can be targeted by the antipsychotic drug thioridazine. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12123675.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1579_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","volume":"54","author":"V Deretic","year":"2021","unstructured":"Deretic V. Autophagy in inflammation, infection, and immunometabolism. Immunity. 2021;54(3):437\u201353.","journal-title":"Immunity"},{"issue":"10","key":"1579_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: Regulator of cell death. Cell Death Dis. 2023;14(10):648.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1579_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41576-022-00562-w","volume":"24","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Zhang S, Mizushima N. Autophagy genes in biology and disease. Nat Rev Genet. 2023;24(6):382\u2013400.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1579_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","volume":"24","author":"JNS Vargas","year":"2023","unstructured":"Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023;24(3):167\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1579_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bulcan.2020.11.004","volume":"108","author":"W Cao","year":"2021","unstructured":"Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer. 2021;108(3):304\u201322.","journal-title":"Bull Cancer"},{"key":"1579_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102428","volume":"100","author":"N Wu","year":"2024","unstructured":"Wu N, Zheng W, Zhou Y, Tian Y, Tang M, Feng X, et al. Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential. Ageing Res Rev. 2024;100:102428.","journal-title":"Ageing Res Rev"},{"key":"1579_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-59745-157-4_15","volume":"445","author":"S Kaushik","year":"2008","unstructured":"Kaushik S, Cuervo AM. Chaperone-mediated autophagy. Methods Mol Biol. 2008;445:227\u201344.","journal-title":"Methods Mol Biol"},{"key":"1579_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-cellbio-120219-035530","volume":"37","author":"T Lamark","year":"2021","unstructured":"Lamark T, Johansen T. Mechanisms of Selective Autophagy. Annu Rev Cell Dev Biol. 2021;37:143\u201369.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"1579_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/bab.2104","volume":"69","author":"L Kma","year":"2022","unstructured":"Kma L, Baruah TJ. The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation. Biotechnol Appl Biochem. 2022;69(1):248\u201364.","journal-title":"Biotechnol Appl Biochem"},{"issue":"7","key":"1579_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166400","volume":"1868","author":"R Rakesh","year":"2022","unstructured":"Rakesh R, PriyaDharshini LC, Sakthivel KM, Rasmi R. Role and regulation of autophagy in cancer. Biochim et Biophys Acta (BBA) - Mol Basis of Dis. 2022;1868(7):166400.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis of Dis"},{"key":"1579_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010179","author":"CW Yun","year":"2020","unstructured":"Yun CW, Jeon J, Go G, Lee JH, Lee SH. The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010179.","journal-title":"Int J Mol Sci"},{"key":"1579_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.578418","volume":"10","author":"R Chavez-Dominguez","year":"2020","unstructured":"Chavez-Dominguez R, Perez-Medina M, Lopez-Gonzalez JS, Galicia-Velasco M, Aguilar-Cazares D. The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity. Front Oncol. 2020;10:578418.","journal-title":"Front Oncol"},{"key":"1579_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216307","volume":"570","author":"Y Qin","year":"2023","unstructured":"Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.","journal-title":"Cancer Lett"},{"issue":"3","key":"1579_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/ajco.13449","volume":"17","author":"RM Usman","year":"2021","unstructured":"Usman RM, Razzaq F, Akbar A, Farooqui AA, Iftikhar A, Latif A, et al. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia Pac J Clin Oncol. 2021;17(3):193\u2013208.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"1579_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13(1):159.","journal-title":"J Hematol Oncol"},{"issue":"51","key":"1579_CR38","doi-asserted-by":"publisher","first-page":"85332","DOI":"10.18632\/oncotarget.13352","volume":"7","author":"TW Kim","year":"2016","unstructured":"Kim TW, Lee SJ, Kim JT, Kim SJ, Min JK, Bae KH, et al. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer. Oncotarget. 2016;7(51):85332\u201348.","journal-title":"Oncotarget"},{"key":"1579_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2018.05.046","volume":"431","author":"X Cheng","year":"2018","unstructured":"Cheng X, Feng H, Wu H, Jin Z, Shen X, Kuang J, et al. Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. Cancer Lett. 2018;431:105\u201314.","journal-title":"Cancer Lett"},{"issue":"18","key":"1579_CR40","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.7150\/jca.24201","volume":"9","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, Xia G, Li N, Su R, Chen X, Zhong L. Autophagy inhibition promotes bevacizumab-induced apoptosis and proliferation inhibition in colorectal cancer cells. J Cancer. 2018;9(18):3407\u201316.","journal-title":"J Cancer"},{"issue":"10","key":"1579_CR41","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1158\/1535-7163.MCT-17-0131","volume":"17","author":"AJ Scott","year":"2018","unstructured":"Scott AJ, Arcaroli JJ, Bagby SM, Yahn R, Huber KM, Serkova NJ, et al. Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived tumor xenograft models via autophagy and signaling mechanisms. Mol Cancer Ther. 2018;17(10):2112\u201322.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1579_CR42","first-page":"143","volume":"27","author":"H Du","year":"2012","unstructured":"Du H, Yang W, Chen L, Shi M, Seewoo V, Wang J, et al. Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells. Oncol Rep. 2012;27(1):143\u201350.","journal-title":"Oncol Rep"},{"issue":"8","key":"1579_CR43","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.4161\/auto.5.8.9996","volume":"5","author":"J Song","year":"2009","unstructured":"Song J, Qu Z, Guo X, Zhao Q, Zhao X, Gao L, et al. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy. 2009;5(8):1131\u201344.","journal-title":"Autophagy"},{"key":"1579_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113896","volume":"175","author":"NH Patel","year":"2020","unstructured":"Patel NH, Xu J, Saleh T, Wu Y, Lima S, Gewirtz DA. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells. Biochem Pharmacol. 2020;175:113896.","journal-title":"Biochem Pharmacol"},{"key":"1579_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102043","volume":"88","author":"L Mele","year":"2020","unstructured":"Mele L, Del Vecchio V, Liccardo D, Prisco C, Schwerdtfeger M, Robinson N, et al. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 2020;88:102043.","journal-title":"Cancer Treat Rev"},{"key":"1579_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1579_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1192\/bjp.2023.131","volume":"224","author":"RA McCutcheon","year":"2024","unstructured":"McCutcheon RA, Cannon A, Parmer S, Howes OD. How to classify antipsychotics: time to ditch dichotomies? Br J Psychiatry. 2024;224(1):20\u20135.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1579_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1017\/S1461145713000801","volume":"17","author":"K Sahlholm","year":"2014","unstructured":"Sahlholm K, Marcellino D, Nilsson J, Ogren SO, Fuxe K, Arhem P. Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor. Int J Neuropsychopharmacol. 2014;17(1):149\u201355.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1579_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-9-57","volume":"9","author":"KH Choi","year":"2009","unstructured":"Choi KH, Higgs BW, Weis S, Song J, Llenos IC, Dulay JR, et al. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry. 2009;9:57.","journal-title":"BMC Psychiatry"},{"key":"1579_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106078","volume":"176","author":"A de Bartolomeis","year":"2022","unstructured":"de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res. 2022;176:106078.","journal-title":"Pharmacol Res"},{"key":"1579_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.phrs.2018.12.001","volume":"139","author":"C Quintana","year":"2019","unstructured":"Quintana C, Beaulieu JM. A fresh look at cortical dopamine D2 receptor expressing neurons. Pharmacol Res. 2019;139:440\u20135.","journal-title":"Pharmacol Res"},{"key":"1579_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249532","author":"D Grinchii","year":"2020","unstructured":"Grinchii D, Dremencov E. Mechanism of action of atypical antipsychotic drugs in mood disorders. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249532.","journal-title":"Int J Mol Sci"},{"key":"1579_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112946","volume":"397","author":"G Unal","year":"2021","unstructured":"Unal G, Sirvanci S, Aricioglu F. alpha7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats. Behav Brain Res. 2021;397:112946.","journal-title":"Behav Brain Res"},{"issue":"7","key":"1579_CR54","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","volume":"27","author":"TH Svensson","year":"2003","unstructured":"Svensson TH. Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(7):1145\u201358.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"1579_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19(1):15\u201333.","journal-title":"World Psychiatry"},{"issue":"Suppl 2","key":"1579_CR56","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.33549\/physiolres.935099","volume":"72","author":"J Rafcikova","year":"2023","unstructured":"Rafcikova J, Novakova M, Stracina T. Exploring the association between schizophrenia and cardiovascular diseases: insights into the role of sigma 1 receptor. Physiol Res. 2023;72(Suppl 2):S113\u201326.","journal-title":"Physiol Res"},{"key":"1579_CR57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/16833_2024_394","volume-title":"Cancer treatment modalities: an interdisciplinary approach","author":"MM Borovcanin","year":"2024","unstructured":"Borovcanin MM, Stojanovic B, Dimitrijevic Stojanovic M, Stojanovic BS, Lazovic A, Mitrovic M. Anticancer properties of antipsychotic drugs. In: Cancer treatment modalities: an interdisciplinary approach. Springer; 2024. p. 551\u201376."},{"key":"1579_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051046","author":"JY Jeong","year":"2022","unstructured":"Jeong JY, Park H, Yoo H, Kim EJ, Jeon B, Lee JD, et al. Trifluoperazine and its analog suppressed the tumorigenicity of non-small cell lung cancer cell; applicability of antipsychotic drugs to lung cancer treatment. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051046.","journal-title":"Biomedicines"},{"issue":"12","key":"1579_CR59","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","volume":"3","author":"NS Jahchan","year":"2013","unstructured":"Jahchan NS, Dudley JT, Mazur PK, Flores N, Yang D, Palmerton A, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 2013;3(12):1364\u201377.","journal-title":"Cancer Discov"},{"issue":"24","key":"1579_CR60","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1080\/15384101.2020.1850969","volume":"19","author":"Y Song","year":"2020","unstructured":"Song Y, Li L, Chen J, Chen H, Cui B, Feng Y, et al. Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0\/G1 arrest and apoptosis. Cell Cycle. 2020;19(24):3521\u201333.","journal-title":"Cell Cycle"},{"key":"1579_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109598","volume":"121","author":"Q Xue","year":"2020","unstructured":"Xue Q, Liu Z, Feng Z, Xu Y, Zuo W, Wang Q, et al. Penfluridol: an antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0\/G1 arrest and apoptosis. Biomed Pharmacother. 2020;121:109598.","journal-title":"Biomed Pharmacother"},{"issue":"30","key":"1579_CR62","doi-asserted-by":"publisher","first-page":"20467","DOI":"10.1039\/D3RA03926A","volume":"13","author":"AK Drabczyk","year":"2023","unstructured":"Drabczyk AK, Kulaga D, Zareba P, Tylinska W, Bachowski W, Archala A, et al. Eco-friendly synthesis of new olanzapine derivatives and evaluation of their anticancer potential. RSC Adv. 2023;13(30):20467\u201376.","journal-title":"RSC Adv"},{"issue":"1","key":"1579_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2302413","volume":"25","author":"G Jiang","year":"2024","unstructured":"Jiang G, Zhou X, Hu Y, Tan X, Wang D, Yang L, et al. The antipsychotic drug pimozide promotes apoptosis through the RAF\/ERK pathway and enhances autophagy in breast cancer cells. Cancer Biol Ther. 2024;25(1):2302413.","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"1579_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1046-3","volume":"9","author":"Z Feng","year":"2018","unstructured":"Feng Z, Xia Y, Gao T, Xu F, Lei Q, Peng C, et al. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis. Cell Death Dis. 2018;9(10):1006.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1579_CR65","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102030","volume":"39","author":"KA Jacobs","year":"2020","unstructured":"Jacobs KA, Andre-Gregoire G, Maghe C, Thys A, Li Y, Harford-Wright E, et al. Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis. EMBO J. 2020;39(1):e102030.","journal-title":"EMBO J"},{"key":"1579_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108888","volume":"315","author":"HCD Medeiros","year":"2020","unstructured":"Medeiros HCD, Colturato-Kido C, Ferraz LS, Costa CA, Moraes VWR, Paredes-Gamero EJ, et al. AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia. Chem Biol Interact. 2020;315:108888.","journal-title":"Chem Biol Interact"},{"issue":"11","key":"1579_CR67","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.21873\/anticanres.11172","volume":"36","author":"JH Cheon","year":"2016","unstructured":"Cheon JH, Lee BM, Kim HS, Yoon S. Highly Halaven-resistant KBV20C cancer cells can be sensitized by co-treatment with fluphenazine. Anticancer Res. 2016;36(11):5867\u201374.","journal-title":"Anticancer Res"},{"issue":"13","key":"1579_CR68","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.18632\/oncotarget.2063","volume":"5","author":"MS Park","year":"2014","unstructured":"Park MS, Dong SM, Kim BR, Seo SH, Kang S, Lee EJ, et al. Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2\/PI3K\/mTOR pathway in ovarian cancer xenografts. Oncotarget. 2014;5(13):4929\u201334.","journal-title":"Oncotarget"},{"issue":"9","key":"1579_CR69","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","volume":"17","author":"S Kang","year":"2012","unstructured":"Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, et al. Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells. Apoptosis. 2012;17(9):989\u201397.","journal-title":"Apoptosis"},{"issue":"4","key":"1579_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/bjc.2017.200","volume":"117","author":"OF Kuzu","year":"2017","unstructured":"Kuzu OF, Gowda R, Noory MA, Robertson GP. Modulating cancer cell survival by targeting intracellular cholesterol transport. Br J Cancer. 2017;117(4):513\u201324.","journal-title":"Br J Cancer"},{"issue":"1","key":"1579_CR71","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046-021-02144-w","volume":"40","author":"S Matteoni","year":"2021","unstructured":"Matteoni S, Matarrese P, Ascione B, Ricci-Vitiani L, Pallini R, Villani V, et al. Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response. J Exp Clin Cancer Res. 2021;40(1):347.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"1579_CR72","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tips.2025.03.005","volume":"46","author":"MI De Silva","year":"2025","unstructured":"De Silva MI, Gan HK, Bardy C. Repurposing trifluoperazine for glioblastoma treatment. Trends Pharmacol Sci. 2025;46(5):392\u2013406.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1579_CR73","first-page":"459","volume":"9","author":"F Xu","year":"2019","unstructured":"Xu F, Xia Y, Feng Z, Lin W, Xue Q, Jiang J, et al. Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases. Am J Cancer Res. 2019;9(3):459\u201378.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"1579_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/ijnpnd.IJNPND_82_21","volume":"12","author":"VV Vedam","year":"2022","unstructured":"Vedam VV, Nuthalapati P, Ghanta MK, David DC, Vijayalakshmi M, Potla KM, et al. Antiproliferative effects of olanzapine against MCF-7 cells and its molecular interactions with survivin. Int J Nutr Pharmacol Neurol Dis. 2022;12(2):72\u20138.","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"issue":"5","key":"1579_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00685561","volume":"34","author":"KS Sridhar","year":"1994","unstructured":"Sridhar KS, Krishan A, Samy TS, Duncan RC, Sauerteig A, McPhee GV, et al. Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker. Cancer Chemother Pharmacol. 1994;34(5):377\u201384.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1579_CR76","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopha.2018.06.170","volume":"106","author":"K Sroda-Pomianek","year":"2018","unstructured":"Sroda-Pomianek K, Michalak K, Swiatek P, Pola A, Palko-Labuz A, Wesolowska O. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo\/Dx in the presence of newly synthesized phenothiazine derivatives. Biomed Pharmacother. 2018;106:624\u201336.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1579_CR77","doi-asserted-by":"publisher","first-page":"e2709","DOI":"10.1038\/cddis.2017.130","volume":"8","author":"S Klutzny","year":"2017","unstructured":"Klutzny S, Lesche R, Keck M, Kaulfuss S, Schlicker A, Christian S, et al. Functional inhibition of acid sphingomyelinase by fluphenazine triggers hypoxia-specific tumor cell death. Cell Death Dis. 2017;8(3):e2709.","journal-title":"Cell Death Dis"},{"issue":"12","key":"1579_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22605","volume":"9","author":"C Su","year":"2023","unstructured":"Su C, Cheng CY, Rong Z, Yang JC, Li ZM, Yao JY, et al. Repurposing fluphenazine as an autophagy modulator for treating liver cancer. Heliyon. 2023;9(12):e22605.","journal-title":"Heliyon"},{"key":"1579_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114403","volume":"184","author":"AJ Jhou","year":"2021","unstructured":"Jhou AJ, Chang HC, Hung CC, Lin HC, Lee YC, Liu WT, et al. Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer. Biochem Pharmacol. 2021;184:114403.","journal-title":"Biochem Pharmacol"},{"key":"1579_CR80","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.biopha.2017.11.012","volume":"97","author":"X Jiang","year":"2018","unstructured":"Jiang X, Chen Z, Shen G, Jiang Y, Wu L, Li X, et al. Psychotropic agent thioridazine elicits potent in vitro and in vivo anti-melanoma effects. Biomed Pharmacother. 2018;97:833\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1579_CR81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-020-1534-z","volume":"39","author":"C Abbruzzese","year":"2020","unstructured":"Abbruzzese C, Matteoni S, Persico M, Villani V, Paggi MG. Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps. J Exp Clin Cancer Res. 2020;39(1):26.","journal-title":"J Exp Clin Cancer Res"},{"issue":"39","key":"1579_CR82","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.18632\/oncotarget.26994","volume":"10","author":"MNA Kamarudin","year":"2019","unstructured":"Kamarudin MNA, Parhar I. Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review. Oncotarget. 2019;10(39):3952\u201377.","journal-title":"Oncotarget"},{"issue":"6","key":"1579_CR83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3892\/ol.2022.13302","volume":"23","author":"M Otreba","year":"2022","unstructured":"Otreba M, Stojko J, Kabala-Dzik A, Rzepecka-Stojko A. Perphenazine and prochlorperazine decrease glioblastoma U-87 MG cell migration and invasion: Analysis of the ABCB1 and ABCG2 transporters, E-cadherin, alpha-tubulin and integrins (alpha3, alpha5, and beta1) levels. Oncol Lett. 2022;23(6):182.","journal-title":"Oncol Lett"},{"issue":"1","key":"1579_CR84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-017-0588-z","volume":"36","author":"X Zhang","year":"2017","unstructured":"Zhang X, Xu R, Zhang C, Xu Y, Han M, Huang B, et al. Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination. J Exp Clin Cancer Res. 2017;36(1):118.","journal-title":"J Exp Clin Cancer Res"},{"key":"1579_CR85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pnpbp.2017.10.012","volume":"81","author":"SH Kim","year":"2018","unstructured":"Kim SH, Park S, Yu HS, Ko KH, Park HG, Kim YS. The antipsychotic agent clozapine induces autophagy via the AMPK-ULK1-Beclin1 signaling pathway in the rat frontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:96\u2013104.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"1579_CR86","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.devcel.2016.04.018","volume":"37","author":"ML Goodall","year":"2016","unstructured":"Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, et al. The autophagy machinery controls cell death switching between apoptosis and necroptosis. Dev Cell. 2016;37(4):337\u201349.","journal-title":"Dev Cell"},{"issue":"9","key":"1579_CR87","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528\u201342.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1579_CR88","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1579_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100.","journal-title":"Mol Cancer"},{"key":"1579_CR90","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","volume":"4","author":"L Poillet-Perez","year":"2015","unstructured":"Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 2015;4:184\u201392.","journal-title":"Redox Biol"},{"issue":"20","key":"1579_CR91","doi-asserted-by":"publisher","first-page":"10140","DOI":"10.18632\/oncotarget.2471","volume":"5","author":"H Zhou","year":"2014","unstructured":"Zhou H, Shen T, Shang C, Luo Y, Liu L, Yan J, et al. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Oncotarget. 2014;5(20):10140\u201350.","journal-title":"Oncotarget"},{"issue":"12","key":"1579_CR92","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/pros.22837","volume":"74","author":"ER Hahm","year":"2014","unstructured":"Hahm ER, Sakao K, Singh SV. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate. 2014;74(12):1209\u201321.","journal-title":"Prostate"},{"issue":"7","key":"1579_CR93","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/15384047.2015.1046022","volume":"16","author":"D Zhang","year":"2015","unstructured":"Zhang D, Tang B, Xie X, Xiao YF, Yang SM, Zhang JW. The interplay between DNA repair and autophagy in cancer therapy. Cancer Biol Ther. 2015;16(7):1005\u201313.","journal-title":"Cancer Biol Ther"},{"key":"1579_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28227594","author":"L He","year":"2023","unstructured":"He L, Fu Y, Tian Y, Wang X, Zhou X, Ding RB, et al. Antidepressants as autophagy modulators for cancer therapy. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28227594.","journal-title":"Molecules"},{"issue":"2-3","key":"1579_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.schres.2011.02.018","volume":"129","author":"FH Chou","year":"2011","unstructured":"Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res. 2011;129(2\u20133):97\u2013103.","journal-title":"Schizophr Res"},{"key":"1579_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.05.031","volume":"856","author":"N Hendouei","year":"2019","unstructured":"Hendouei N, Saghafi F, Shadfar F, Hosseinimehr SJ. Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment. Eur J Pharmacol. 2019;856:172402.","journal-title":"Eur J Pharmacol"},{"key":"1579_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/life11040365","author":"C Colturato-Kido","year":"2021","unstructured":"Colturato-Kido C, Lopes RM, Medeiros HCD, Costa CA, Prado-Souza LFL, Ferraz LS, et al. Inhibition of autophagy enhances the antitumor effect of thioridazine in acute lymphoblastic leukemia cells. Life (Basel). 2021. https:\/\/doi.org\/10.3390\/life11040365.","journal-title":"Life (Basel)"},{"issue":"Supp 1","key":"1579_CR98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2165\/00002018-199200071-00008","volume":"7","author":"PA Veys","year":"1992","unstructured":"Veys PA, Wilkes S, Shah S, Noyelle R, Hoffbrand AV. Clinical experience of clozapine-induced neutropenia in the UK Laboratory investigation using liquid culture systems and immunofluorocytometry. Drug Saf. 1992;7(Supp 1):26\u201332.","journal-title":"Drug Saf."},{"issue":"3","key":"1579_CR99","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1159\/000369751","volume":"35","author":"YC Yin","year":"2015","unstructured":"Yin YC, Lin CC, Chen TT, Chen JY, Tsai HJ, Wang CY, et al. Clozapine induces autophagic cell death in non-small cell lung cancer cells. Cell Physiol Biochem. 2015;35(3):945\u201356.","journal-title":"Cell Physiol Biochem"},{"key":"1579_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105295","volume":"163","author":"Y Xia","year":"2021","unstructured":"Xia Y, Xu F, Xiong M, Yang H, Lin W, Xie Y, et al. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacol Res. 2021;163:105295.","journal-title":"Pharmacol Res"},{"issue":"2","key":"1579_CR101","first-page":"545","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ding K, Ji J, Parajuli H, Aasen SN, Espedal H, et al. Trifluoperazine prolongs the survival of experimental brain metastases by STAT3-dependent lysosomal membrane permeabilization. Am J Cancer Res. 2020;10(2):545\u201363.","journal-title":"Am J Cancer Res"},{"issue":"51","key":"1579_CR102","doi-asserted-by":"publisher","first-page":"20364","DOI":"10.1073\/pnas.1319661110","volume":"110","author":"Y Liu","year":"2013","unstructured":"Liu Y, Shoji-Kawata S, Sumpter RM Jr., Wei Y, Ginet V, Zhang L, et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A. 2013;110(51):20364\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1579_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225661","author":"S Ramachandran","year":"2021","unstructured":"Ramachandran S, Kaushik IS, Srivastava SK. Pimavanserin: a novel autophagy modulator for pancreatic cancer treatment. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13225661.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1579_CR104","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41419-022-04828-3","volume":"13","author":"MC Tung","year":"2022","unstructured":"Tung MC, Lin YW, Lee WJ, Wen YC, Liu YC, Chen JQ, et al. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis. Cell Death Dis. 2022;13(4):400.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1579_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018691","volume":"6","author":"W Han","year":"2011","unstructured":"Han W, Pan H, Chen Y, Sun J, Wang Y, Li J, et al. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS ONE. 2011;6(6):e18691.","journal-title":"PLoS ONE"},{"issue":"9","key":"1579_CR106","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.21873\/anticanres.15237","volume":"41","author":"S Suzuki","year":"2021","unstructured":"Suzuki S, Yamamoto M, Sanomachi T, Togashi K, Seino S, Sugai A, et al. Lurasidone sensitizes cancer cells to osimertinib by inducing autophagy and reduction of survivin. Anticancer Res. 2021;41(9):4321\u201331.","journal-title":"Anticancer Res"},{"issue":"3\u20134","key":"1579_CR107","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","volume":"25","author":"SI Omoruyi","year":"2020","unstructured":"Omoruyi SI, Ekpo OE, Semenya DM, Jardine A, Prince S. Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. Apoptosis. 2020;25(3\u20134):261\u201374.","journal-title":"Apoptosis"},{"issue":"5","key":"1579_CR108","doi-asserted-by":"publisher","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","volume":"6","author":"HW Cheng","year":"2015","unstructured":"Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6(5):e1753.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1579_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14737140.2022.1987221","volume":"22","author":"GD Lianos","year":"2022","unstructured":"Lianos GD, Alexiou GA, Rausei S, Galani V, Mitsis M, Kyritsis AP. Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives. Expert Rev Anticancer Ther. 2022;22(2):131\u20134.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1579_CR110","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.canlet.2018.01.058","volume":"419","author":"J Huang","year":"2018","unstructured":"Huang J, Zhao D, Liu Z, Liu F. Repurposing psychiatric drugs as anti-cancer agents. Cancer Lett. 2018;419:257\u201365.","journal-title":"Cancer Lett"},{"issue":"14","key":"1579_CR111","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.18632\/oncotarget.28010","volume":"12","author":"P Kamgar-Dayhoff","year":"2021","unstructured":"Kamgar-Dayhoff P, Brelidze TI. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment. Oncotarget. 2021;12(14):1406\u201326.","journal-title":"Oncotarget"},{"key":"1579_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104809","volume":"141","author":"JS Brown","year":"2022","unstructured":"Brown JS. Treatment of cancer with antipsychotic medications: pushing the boundaries of schizophrenia and cancer. Neurosci Biobehav Rev. 2022;141:104809.","journal-title":"Neurosci Biobehav Rev"},{"key":"1579_CR113","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2017.06.26","author":"J-F Lin","year":"2017","unstructured":"Lin J-F, Hwang TI. Autophagy regulation in bladder cancer as the novel therapeutic strategy. Transl Cancer Res. 2017. https:\/\/doi.org\/10.21037\/tcr.2017.06.26.","journal-title":"Transl Cancer Res"},{"issue":"9","key":"1579_CR114","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10(9):1533\u201341.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1579_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40610-023-00151-8","volume":"9","author":"S Borhani","year":"2023","unstructured":"Borhani S. Autophagy in cancer therapy: advances and prospects. Curr Mol Biol Rep. 2023;9(1):1\u20137.","journal-title":"Curr Mol Biol Rep"},{"issue":"5","key":"1579_CR116","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","volume":"44","author":"V Jain","year":"2023","unstructured":"Jain V, Singh MP, Amaravadi RK. Recent advances in targeting autophagy in cancer. Trends Pharmacol Sci. 2023;44(5):290\u2013302.","journal-title":"Trends Pharmacol Sci"},{"key":"1579_CR117","doi-asserted-by":"publisher","first-page":"1247079","DOI":"10.3389\/fcvm.2024.1247079","volume":"11","author":"X Deng","year":"2024","unstructured":"Deng X, Yang Z, Li T, Wang Y, Yang Q, An R, et al. Identification of 4 autophagy-related genes in heart failure by bioinformatics analysis and machine learning. Front Cardiovasc Med. 2024;11:1247079.","journal-title":"Front Cardiovasc Med."},{"issue":"1-2","key":"1579_CR118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1\u20132):11\u201342.","journal-title":"Cell"},{"issue":"1","key":"1579_CR119","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/15548627.2023.2250217","volume":"20","author":"EI Lewerissa","year":"2024","unstructured":"Lewerissa EI, Nadif Kasri N, Linda K. Epigenetic regulation of autophagy-related genes: implications for neurodevelopmental disorders. Autophagy. 2024;20(1):15\u201328.","journal-title":"Autophagy"},{"key":"1579_CR120","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a001578","author":"EI Dumbrava","year":"2018","unstructured":"Dumbrava EI, Meric-Bernstam F. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making. Cold Spring Harb Mol Case Stud. 2018. https:\/\/doi.org\/10.1101\/mcs.a001578.","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"1579_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041009","author":"V Gambardella","year":"2020","unstructured":"Gambardella V, Tarazona N, Cejalvo JM, Lombardi P, Huerta M, Rosello S, et al. Personalized medicine: recent progress in cancer therapy. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12041009.","journal-title":"Cancers (Basel)"},{"key":"1579_CR122","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8833","author":"A Ali Ibrahim Mze","year":"2024","unstructured":"Ali Ibrahim Mze A, Abdul Rahman A. Repurposing the antipsychotic drug penfluridol for cancer treatment (review). Oncol Rep. 2024. https:\/\/doi.org\/10.3892\/or.2024.8833.","journal-title":"Oncol Rep"},{"key":"1579_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.966012","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhu Y, Zhang J, Zhang L, Chen L. Inhibiting cytoprotective autophagy in cancer therapy: an update on pharmacological small-molecule compounds. Front Pharmacol. 2022;13:966012.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1579_CR124","doi-asserted-by":"publisher","first-page":"15753","DOI":"10.1038\/s41598-018-33740-0","volume":"8","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhang C, Liu F, Mao Y, Xu W, Fan T, et al. Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases. Sci Rep. 2018;8(1):15753.","journal-title":"Sci Rep"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01579-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:21Z","timestamp":1787065341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01579-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":124,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01579-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No financial support was received for the conduct of this study, or for the preparation or publication of this manuscript.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OV conceived and designed the study. EOS, SP, SD, ZMC, MT, SY, and OV contributed to data collection, writing-original draft, and writing-review & editing. MT was responsible for visualization and figure illustration. SY and OV, as project administrators, critically reviewed and revised the initial draft. The entire study was conducted under the supervision of OV. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.","order":8,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}